FTC and Four States Sue WPATH Over Gender-Affirming Care Claims

The Federal Trade Commission (FTC) and four states—Alaska, Iowa, Nebraska, and Texas—have sued the World Professional Association for Transgender Health (WPATH), alleging the group made deceptive claims about gender-affirming care for minors to prioritize profit. WPATH denies these allegations, claiming the lawsuit is a retaliatory attack on First Amendment rights and professional medical independence.

Why is the FTC suing WPATH?

The lawsuit centers on claims that WPATH used deceptive marketing and guidance regarding gender-affirming care for minors. According to FTC Chair Andrew Ferguson, the agency’s goal is to ensure parents can make informed health decisions without being “deceived by medical organizations and providers who are prioritizing profit over children’s health and safety.”

WPATH argues its guidelines aren’t a “one size fits all” mandate. In a public statement, the organization emphasized that its standards call for care tailored to the specific needs of individual patients. The group maintains its guidelines are based on expert consensus and scientific standards developed over more than 50 years.

What happens next for medical guidelines?

This legal action signals a broader shift toward federal scrutiny of professional medical associations. The FTC has already launched investigations into the American Academy of Pediatrics and the Endocrine Society over their respective guidelines on gender-affirming care. Both organizations have filed lawsuits to block those probes.

The trend suggests a move away from relying solely on professional consensus. Instead, medical standards are increasingly being contested in courtrooms. If the FTC successfully proves that these guidelines constitute “deceptive claims,” it could set a precedent allowing the government to regulate the clinical guidelines issued by non-governmental professional bodies.

The conflict between consumer protection and clinical speech

The core of the legal battle is whether medical guidelines are “commercial speech” (which the FTC can regulate for deception) or “professional speech” protected by the First Amendment. WPATH claims the FTC is acting out of “pure retaliation” as part of a targeted campaign to undermine transgender healthcare.

A federal judge already ruled in favor of WPATH in May, temporarily blocking an earlier FTC investigation. WPATH expects a similar result in this new lawsuit, citing the independence of professional medical organizations as a constitutional priority.

How will this impact gender-affirming care for minors?

The immediate impact is a climate of legal uncertainty for providers. Because WPATH guidelines are widely accepted, a legal ruling labeling them “deceptive” could leave doctors without a standard-of-care shield in malpractice or criminal cases, particularly in the four states leading the suit.

We are seeing a divergence in care models. While some providers continue to follow WPATH’s patient-centered approach, others are shifting toward more restrictive protocols to avoid legal risk. This creates a “zip code lottery” where the available medical care for a minor depends entirely on their state of residence.

Comparing the Arguments

Frequently Asked Questions

Who is suing WPATH?
The Federal Trade Commission (FTC) and the states of Alaska, Iowa, Nebraska, and Texas.

What is WPATH?
The World Professional Association for Transgender Health, an organization that sets international standards of care for transgender and gender-diverse people.

What is the main allegation in the lawsuit?
The FTC alleges that WPATH made deceptive claims about gender-affirming care for minors and that its members profited from these claims.

Has a court already ruled on this?
Yes, a federal judge ruled in May to temporarily block a previous FTC investigation into WPATH, which the organization now cites as a defense against the current suit.